Movatterモバイル変換


[0]ホーム

URL:


GB2442615A - Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer - Google Patents

Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
Download PDF

Info

Publication number
GB2442615A
GB2442615AGB0720886AGB0720886AGB2442615AGB 2442615 AGB2442615 AGB 2442615AGB 0720886 AGB0720886 AGB 0720886AGB 0720886 AGB0720886 AGB 0720886AGB 2442615 AGB2442615 AGB 2442615A
Authority
GB
United Kingdom
Prior art keywords
modified release
cancer
treatment
fluorocytidine derivative
release compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB0720886A
Other versions
GB0720886D0 (en
Inventor
Scott Jenkins
Gary Liversidge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharma International Ltd
Original Assignee
Elan Pharma International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharma International LtdfiledCriticalElan Pharma International Ltd
Publication of GB0720886D0publicationCriticalpatent/GB0720886D0/en
Publication of GB2442615ApublicationCriticalpatent/GB2442615A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention relates to a multiparticulate modified release composition comprising a fluorocytidine derivative, preferably capecitabine, and a modified release component comprising a modified release coating, a modified release matrix material, or both. Following oral delivery, the composition in operation delivers the fluorocytidine derivative in a pulsatile manner at about six to about twelve hours after administration.
GB0720886A2005-04-122006-04-12Modified release compositions comprising a fluorocytidine derivative for the treatment of cancerPendingGB2442615A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US67050705P2005-04-122005-04-12
PCT/US2006/013629WO2006110800A1 (en)2005-04-122006-04-12Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer

Publications (2)

Publication NumberPublication Date
GB0720886D0 GB0720886D0 (en)2007-12-05
GB2442615Atrue GB2442615A (en)2008-04-09

Family

ID=37087358

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0720886APendingGB2442615A (en)2005-04-122006-04-12Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer

Country Status (7)

CountryLink
EP (1)EP1874271A4 (en)
JP (1)JP2008535920A (en)
CA (1)CA2604192A1 (en)
DE (1)DE112006000873T5 (en)
ES (1)ES2327195B1 (en)
GB (1)GB2442615A (en)
WO (1)WO2006110800A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20080085310A1 (en)*2006-10-062008-04-10Maria Oksana BachynskyCapecitabine rapidly disintegrating tablets
US20110027374A1 (en)*2008-12-162011-02-03Maria Oksana BachynskyCapecitabine rapidly disintegrating tablets
AU2016280148A1 (en)*2015-06-132018-01-04Intas Pharmaceuticals Ltd.Extended release Capecitabine capsules
JP2020514314A (en)*2017-02-062020-05-21インタス ファーマシューティカルズ リミテッド Compositions containing immediate release and sustained release capecitabine

Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6228398B1 (en)*1998-11-022001-05-08Elan Corporation, PlcMultiparticulate modified release composition
US6503889B2 (en)*2000-02-282003-01-07Aventis Pharma S.A.Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6586006B2 (en)*1994-08-042003-07-01Elan Drug Delivery LimitedSolid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP0954291B1 (en)*1996-10-252005-12-28Shire Laboratories Inc.Soluble form osmotic dose delivery system
US6005098A (en)*1998-02-061999-12-21Hoffmann-La Roche Inc.5'deoxycytidine derivatives
US6248363B1 (en)*1999-11-232001-06-19Lipocine, Inc.Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1440278A (en)*2000-06-022003-09-03希龙公司Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethy lene) cytidine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6228398B1 (en)*1998-11-022001-05-08Elan Corporation, PlcMultiparticulate modified release composition
US6503889B2 (en)*2000-02-282003-01-07Aventis Pharma S.A.Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer

Also Published As

Publication numberPublication date
ES2327195B1 (en)2010-07-09
WO2006110800A1 (en)2006-10-19
CA2604192A1 (en)2006-10-19
EP1874271A4 (en)2012-01-25
JP2008535920A (en)2008-09-04
EP1874271A1 (en)2008-01-09
ES2327195A1 (en)2009-10-26
GB0720886D0 (en)2007-12-05
DE112006000873T5 (en)2008-03-06

Similar Documents

PublicationPublication DateTitle
CA3094580C (en)Oral formulations of cytidine analogs and methods of use thereof
SG171649A1 (en)Dpp iv inhibitor formulations
IL186104A (en)Phosphoramidate derivatives of nucleoside compounds, pharmaceutical compositions comprising same, processes for preparation thereof and their use in the treatment of cancer
MX2007004294A (en)Pharmaceutical compositions comprising levetiracetam and process for their preparation.
MX2009001711A (en)Sustained-release formulations of topiramate.
MY148844A (en)Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
UA93709C2 (en)12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
MX2010002410A (en)Oral compositions, products, and methods of use.
CL2008001839A1 (en) Compounds derived from 2,7-diazaspirocycles, inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1; pharmaceutical composition comprising said compounds; Useful to treat obesity, diabetes, glucose intolerance, type II diabetes, among other diseases.
MY143795A (en)Tetrahydropyridoindole derivatives
MX2009012155A (en)A synergistic pharmaceutical combination for the treatment of cancer.
WO2008124505A3 (en)Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
UA103181C2 (en)Compounds inhibiting dipeptidyl peptidase-iv and pharmaceutical composition comprising thereof as an active agent
ME02450B (en) IMPROVED ANTI-TUMOR TREATMENTS
WO2009020561A3 (en)Compositions and methods of use thereof, for the treatment of oral pain, comprising cloves or extract thereof in combination with a steroid
MX2010009848A (en)Compositions for site-specific delivery of imatinib and methods of use.
MX2010003439A (en)Pharmaceutical combination of aliskiren and valsartan.
IL164440A0 (en)New pharmaceutical composition containing fibanserin polymorph a
MX2009012536A (en)An extended-release composition comprising a somatostatin derivative in microparticles.
GB2442615A (en)Modified release compositions comprising a fluorocytidine derivative for the treatment of cancer
WO2008075320A3 (en)Antilipidemic pharmaceutical compositions and process for preparation thereof
GEP20135733B (en)Novel diazeniumdiolate derivatives, their preparation method and pharmaceutical compositions containing them
UA102111C2 (en)Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
WO2006131566A3 (en)Oral ribavirin pharmaceutical compositions
MX2007005525A (en)Therapeutic treatment of accelerated bone resorption.

[8]ページ先頭

©2009-2025 Movatter.jp